Background: Thyroid cancer (TC) is a rare condition in children. It may be associated with radiation, iodine deficiency or familial inheritance. Aims: The objectives of this study were to analyse the prevalence and incidence trends over 3 decades and clinical features of TC in the paediatric population in Lithuania. Methods: We reviewed all TC cases diagnosed in children aged less than 18 years during the period 1980-2014 using medical records from 3 main hospitals in Lithuania where such TC cases are managed. Results: During the 35-year period (1980-2014) there were 57 cases (45 females) of TC in children in Lithuania. The mean age at the time of diagnosis was 14.51 ± 0.52 years. The crude incidence rate of TC ranged from 0 to 0.93 cases per 100,000 children per year and the mean annual increase was 5.26% (p < 0.001). Papillary carcinoma was the most common histological type (73.7%). No association was found between the incidence of TC and the reported areas of radioactive contamination after the Chernobyl accident. In total, 8.8% of patients had secondary TC after initial radiotherapy of a primary oncologic disease. Conclusion: The incidence of TC in the Lithuanian paediatric population between 1980 and 2014 ranged from 0 to 0.93 cases per 100,000 children per year and there was a 5.26% annual increase (p < 0.001), most probably related to the increased use of ultrasound testing.

Keywords:
Thyroid cancer, Children, Paediatrics, Chernobyl accident, Radiation, Secondary cancer
1.
Demidchik YE, Saenko VA, Yamashita S: Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present. Arq Bras Endocrinol Metabol 2007;51:748-762.
2.
Vaisman F, Corbo R, Vaisman M: Thyroid carcinoma in children and adolescents - systematic review of the literature. J Thyroid Res 2011;2011:845362.
3.
Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, McConahey WM: Papillary thyroid carcinoma in children and adults: long-term follow-up of 1,039 patients conservatively treated at one institution during three decades. Surgery 1988;104:1157-1166.
4.
Park S, Jeong JS, Ryu HR, Lee C-R, Park JH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS: Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the Yonsei University Health System. J Korean Med Sci 2013;28:693-699.
5.
Alessandri AJ, Goddard KJ, Blair GK, Fryer CJ, Schultz KR: Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol 2000;35:41-46.
6.
Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, et al: Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006;26:127-140.
7.
Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, Stiller C, Stevens MC, Hawkins MM: Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer 2009;125:2400-2405.
8.
Collini P, Massimino M, Leite SF, Mattavelli F, Seregni E, Zucchini N, Spreafico F, Ferrari A, Castellani MR, Cantù G, Fossati-Bellani F, Rosai J: Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the Istituto Nazionale Tumori in Milan. Pediatr Blood Cancer 2006;46:300-306.
9.
Pettersson B, Adami HO, Wilander E, Coleman MP: Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type. Int J Cancer 1991;48:28-33.
10.
Bėrontienė R: Structural and Functional Changes Caused by Iodine Deficiency in the Thyroid Gland of Lithuanian Children; dissertation, Kaunas, 2002.
11.
Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynik V, Lubin JH, Zablotska LB, Tereschenko VP, McConnell RJ, Zamotaeva G, O'Kane P, Bouville AC, Chaykovskaya LV, Greenebaum E, Paster IP, Shpak VM, Ron E: I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect 2011;119:933-939.
12.
Zablotska LB, Ron E, Rozhko V, Hatch M, Polyanskaya ON, Brenner AV, Lubin J, Romanov GN, McConnell RJ, O'Kane P, Evseenko VV, Drozdovitch VV, Luckyanov N, Minenko VF, Bouville A, Masyakin VB: Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer 2011;104:181-187.
13.
Niedziela M, Korman E, Breborowicz D, Trejster E, Harasymczuk J, Warzywoda M, Rolski M, Breborowicz J: A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster. Pediatr Blood Cancer 2004;42:84-92.
14.
Nedveckaite T: Radioactive contamination after Chernobyl accident in Lithuania; in Radiation Protection in Lithuania. Vilnius, Kriventa, 2004, pp 103-115.
15.
Auvinen A, Seppä K, Pasanen K, Kurttio P, Patama T, Pukkala E, Heinävaara S, Arvela H, Verkasalo P, Hakulinen T: Chernobyl fallout and cancer incidence in Finland 1988-2007. Int J Cancer 2013;134:2253-2263.
16.
Schlumberger M, Pacini F: The Chernobyl accident; in Schlumberger M, Pacini F (eds): Thyroid Tumors. Paris, Nucleon, 1999, pp 239-243.
17.
Shakhtarin VV, Tsyb AF, Stepanenko VF, Orlov MY, Kopecky KJ, Davis S: Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol 2003;32:584-591.
18.
Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, et al: Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005;97:724-732.
19.
Brito JP, Hay ID, Morris JC: Low risk papillary thyroid cancer. BMJ 2014;348:g3045.
20.
American Cancer Society Network: Cancer facts & figures 2012. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012 (accessed September 23, 2014).
21.
Catelinois O, Laurier D, Verger P, Rogel A, Colonna M, Ignasiak M, Hémon D, Tirmarche M: Uncertainty and sensitivity analysis in assessment of the thyroid cancer risk related to Chernobyl fallout in Eastern France. Risk Anal 2005;25:243-252.
22.
Bleyer A, Viny A, Barr R: Cancer in 15- to 29-year-olds by primary site. Oncologist 2006;11:590-601.
23.
Nottage K, McFarlane J, Krasin MJ, Li C, Srivastava D, Robison LL, Hudson MM: Secondary colorectal carcinoma after childhood cancer. J Clin Oncol 2012;30:2552-2558.
24.
Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, Pritchard-Jones K, Jenkinson HC, Hawkins MM: Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011;305:2311-2319.
25.
Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Mertens AC, Liu Y, Hammond S, Land CE, Neglia JP, Donaldson SS, Meadows AT, Sklar CA, Robison LL, Inskip PD: Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers. Radiat Res 2006;166:618-628.
26.
Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD: Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 2005;365:2014-2023.
27.
Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD: Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010;174:741-752.
28.
Veiga LH, Bhatti P, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Neglia JP, Meadows AT, Donaldson SS: Chemotherapy ant thyroid cancer risk: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 2012;21:92-101.
29.
Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL: Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-629.
30.
Tucker MA, Jones PH, Boice JD, Robison LL, Stone BJ, Stovall M, Jenkin RD, Lubin JH, Baum ES, Siegel SE, Meadows AT, Hoover RN, Fraumeni JF: Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991;51:2885-2888.
© 2016 European Thyroid Association Published by S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.